Dysarthria treatment for Parkinson’s disease: one-year follow-up of SPEAK OUT!^® with the LOUD Crowd^®

References

• Ho AK, Iansek R, Marigliani C, et al. Speech impairment in a large sample of patients with Parkinson’s disease. Behav Neurol. 1999;11:327643.
   Web of Science ®Google Scholar
• Perez-Lloret S, Nègre-Pagès L, Ojero-Senard A et al. Oro-buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson's disease: preliminary analysis from the French COPARK cohort. Eur J Neurol. 2012;19(1):28–37.
   PubMed Web of Science ®Google Scholar
• Schröder C, Nikolova ZT, Dengler R. Changes of emotional prosody in Parkinson’s disease. J Neurol Sci. 2010;289(1–2):32–35.
   PubMed Web of Science ®Google Scholar
• Pinto S, Ozsancak C, Tripoliti E, et al. Treatments for dysarthria in Parkinson’s disease. Lancet Neurol. 2004;3(9):547–556.
   PubMed Web of Science ®Google Scholar
• Miller N, Andrew S, Noble E, et al. Changing perceptions of self as a communicator in Parkinson’s disease: a longitudinal follow-up study. Disabil Rehabil. 2011;33(3):204–210.
   PubMed Web of Science ®Google Scholar
• Prenger MTM, Madray R, Van Hedger K, et al. Social symptoms of Parkinson’s disease. Parkinsons Dis. 2020;2020(2020):8846544.
   PubMedGoogle Scholar
• Moya-Galé G, Levy ES. Parkinson’s disease-associated dysarthria: prevalence, impact and management strategies. Res Rev Park. 2019;9:9–16.
   Google Scholar
• Ramig L, Halpern A, Spielman J, et al. Speech treatment in Parkinson’s disease: randomized controlled trial (RCT). Mov Disord. 2018;33(11):1777–1791.
   PubMed Web of Science ®Google Scholar
• Boutsen F, Park E, Dvorak J, et al. Prosodic improvement in persons with Parkinson disease receiving SPEAK OUT!® voice therapy. Folia Phoniatr Logop. 2018;70(2):51–58.
   PubMed Web of Science ®Google Scholar
• Levy ES, Moya-Galé G, Chang YHM, et al. The effects of intensive speech treatment on intelligibility in Parkinson’s disease: a randomised controlled trial. EClinicalMedicine. 2020;24:100429.
   PubMedGoogle Scholar
• Behrman A, Cody J, Elandary S, et al. The effect of SPEAK OUT! and the LOUD crowd on dysarthria due to Parkinson’s disease. Am J Speech Lang Pathol. 2020;29(3):1448–1465.
   PubMed Web of Science ®Google Scholar
• Wu T, Liu J, Zhang H, et al. Attention to automatic movements in Parkinson’s disease: modified automatic mode in the striatum. Cereb Cortex. 2015;25(10):3330–3342.
   PubMed Web of Science ®Google Scholar
• Watts CR. A retrospective study of long-term treatment outcomes for reduced vocal intensity in hypokinetic dysarthria. BMC Ear Nose Throat Disord. 2016;16:2.
   PubMed Web of Science ®Google Scholar
• Faul F, Erdfelder E, Buchner A, et al. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149–1160.
   PubMed Web of Science ®Google Scholar
• Skodda S, Visser W, Schlegel U. Short- and long-term dopaminergic effects on dysarthria in early Parkinson’s disease. J Neural Transm (Vienna). 2010;117(2):197–205.
   PubMed Web of Science ®Google Scholar
• Sapir S. Multiple factors are involved in the dysarthria associated with Parkinson’s disease: a review with implications for clinical practice and research. J Speech Lang Hear Res. 2014;57(4):1330–1343.
   PubMed Web of Science ®Google Scholar
• Patel R, Connaghan K, Franco D, et al. The caterpillar”: a novel reading passage for assessment of motor speech disorders. Am J Speech Lang Pathol. 2013;22(1):1–9.
   PubMed Web of Science ®Google Scholar
• Jannetts S, Lowit A. Cepstral analysis of hypokinetic and ataxic voices: correlations with perceptual and other acoustic measures. J Voice. 2014;28(6):673–680.
   PubMed Web of Science ®Google Scholar
• Hogikyan ND, Sethuraman G. Validation of an instrument to measure voice-related quality of life (V-RQOL). J Voice. 1999;13(4):557–569.
   PubMed Web of Science ®Google Scholar
• Boersma P, Weenink D. Praat: doing phonetics by computer; 2008. Available from: http://www.praat.org/
   Google Scholar
• Awan SN, Roy N, Jetté ME, et al. Quantifying dysphonia severity using a spectral/cepstral-based acoustic index: comparisons with auditory-perceptual judgements from the CAPE-V. Clin Linguist Phon. 2010;24(9):742–758.
   PubMed Web of Science ®Google Scholar
• Tjaden K, Sussman JE, Wilding GE. Impact of clear, loud, and slow speech on scaled intelligibility and speech severity in Parkinson’s disease and multiple sclerosis. J Speech Lang Hear Res. 2014;57(3):779–792.
   PubMed Web of Science ®Google Scholar
• Moore BCJ. An introduction to the psychology of hearing. 5th ed. London: Elsevier; 2004.
   Google Scholar
• Skodda S, Grönheit W, Schlegel U. Intonation and Speech Rate in Parkinson’s disease: general and dynamic aspects and responsiveness to levodopa admission. J Voice. 2011;25(4):e199–e205.
   PubMed Web of Science ®Google Scholar
• Edison JD, Adams HE. Depression, self-focus, and social interaction. J Psychopathol Behav Assess. 1992;14(1):1–19.
   Web of Science ®Google Scholar
• Dykstra AD, Hakel ME, Adams SG. Application of the ICF in reduced speech intelligibility in dysarthria. Semin Speech Lang. 2007;28(4):301–311.
   PubMedGoogle Scholar
• Maryn Y, De Bodt M, Roy N. The acoustic voice quality index: toward improved treatment outcomes assessment in voice disorders. J Commun Disord. 2010;43(3):161–174.
   PubMed Web of Science ®Google Scholar
• Awan SN, Giovinco A, Owens J. Effects of vocal intensity and vowel type on cepstral analysis of voice. J Voice. 2012;26(5):670.e15–e20.
   PubMed Web of Science ®Google Scholar
• Combs-Miller SA, Moore ES. Predictors of outcomes in exercisers with Parkinson disease: a two-year longitudinal cohort study. NeuroRehabilitation. 2019;44(3):425–432.
   PubMed Web of Science ®Google Scholar
• Rusz J, Hlavnička J, Novotny M, et al. Speech biomarkers in rapid eye movement sleep behavior disorder and Parkinson disease. Ann Neurol. 2021;90(1):62–75.
   PubMed Web of Science ®Google Scholar